White Guide and Orange Guide Formatting Project - Pfizer

More documents

Recommendations

Info

Chapter 2: DETAILING TO HCPs CONTENTS Detailing to HCPs Orange Guide – Chapter 2: Detailing to HCPs Introduction .................................................................................................................................................................... 3 Key Points to Ensure Compliance ........................................................................................................................ 4 Core Compliance Principles for Successful Product Promotion .................................................................................. 5 Use Only RC-Approved Materials and Selling Statements ......................................................................................... 5 Using RC-Approved Materials in Details .............................................................................................................. 5 Selling Statements ............................................................................................................................................... 9 Stay On-Label and Discuss Only Approved Products and Indications...................................................................... 11 Comparative Claims ............................................................................................................................................ 14 Provide an Accurate and Balanced Presentation ....................................................................................................... 15 Never Engage in Actual or Perceived Quid Pro Quo .................................................................................................. 16 Interacting with Employer Representatives and C-Suite Administrators ................................................................ 16 Other Things You Need to Know ................................................................................................................................ 18 Educational Items to HCPs .................................................................................................................................. 18 Interacting with MOS Colleagues ....................................................................................................................... 19 Interacting with RMRS Colleagues .................................................................................................................... 20 Exhibits and Displays ........................................................................................................................................... 21 Call Notes ............................................................................................................................................................. 23 Preceptorships and Other Training for Sales Colleagues .................................................................................. 23 Detailing Activities in Connection with Customer and Other Third Party Meetings .......................................25 16 Rev. 09/12 Page 1 of 29
Orange Guide – Chapter 2: Detailing to HCPs Attendance at Continuing Medical Education events ....................................................................................... 27 FOR MORE INFORMATION ....................................................................................................................................... 28 17 Rev. 09/12 Page 2 of 29
Page 1 and 2: Dear Colleagues: Pfizer Inc 235 Eas
Page 3 and 4: To expand the bookmarks for a chapt
Page 5 and 6: Orange Guide - Chapter 1: Overview
Page 15 and 16: Foreign Corrupt Practices Act Orang
Page 17 and 18: Pfizer’s Corporate Integrity Agre
Page 19: Orange Guide - Chapter 1: Overview
Page 23 and 24: Key Points to Ensure Compliance Ora
Page 25 and 26: Orange Guide - Chapter 2: Detailing
Page 27 and 28: Communicating Formulary Status Mail
Page 33 and 34: Hospital Protocols Comparative Clai
Page 39 and 40: Interacting with RMRS Colleagues Or
Page 47 and 48: Detailing at Journal Club Meetings
Page 49 and 50: Orange Guide - Chapter 3: Support o
Page 55 and 56: Medical Education Grants Overview O
Page 57 and 58: International Grant Activity Orange
Page 61 and 62: “Not-for-Profit” Defined Orange
Page 67 and 68: Information on Pfizer’s External
Page 69 and 70: Overview Orange Guide - Chapter 3:
Page 71 and 72:
Awards, Scholarships and Fellowship
Page 73 and 74:
Orange Guide - Chapter 3: Support o
Page 75 and 76:
Orange Guide - Chapter 4: Federal E
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Promotional Activities Orange Guide
Page 83 and 84:
Page 85 and 86:
Speaker Program Meals Part-Time VA
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Orange Guide - Chapter 5: Interacti
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Discussing Payer Rebates Medical Ac
Page 117 and 118:
Page 119 and 120:
Orange Guide - Chapter 6: Clinical
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Orange Guide - Chapter 7: P&T Commi
Page 129 and 130:
Page 131 and 132:
Questions From a P&T Committee Memb
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Orange Guide - Chapter 8: Privacy:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Seek Only De-Identified Data Orange
Page 147 and 148:
Consent Forms and Mentorships Orang
Page 149 and 150:
REMEMBER Orange Guide - Chapter 8:
Page 151 and 152:
Proper Use of HCP Prescriber Data O
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Orange Guide - Chapter 9: Speaker P
Page 159 and 160:
Page 161 and 162:
Speaker Selection Scheduling Issues
Page 163 and 164:
Use of Pfizer Approved Speaker Slid
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Providing In-Office Meals to Office
Page 171 and 172:
U.S. HCP Payment Disclosure Policy
Page 173 and 174:
Page 175 and 176:
Closeouts Orange Guide - Chapter 9:
Page 177 and 178:
Page 179 and 180:
Physical Separation of Speaker Prog
Page 181 and 182:
Chapter 10: STARTERS CONTENTS Start
Page 183 and 184:
Key Points to Ensure Compliance Ora
Page 185 and 186:
Orange Guide - Chapter 10: Starters
Page 187 and 188:
Inclusion of Materials with Starter
Page 189 and 190:
Page 191 and 192:
Distribution of Starters to Colleag
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Orange Guide - Chapter 11: Patient
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
A special note about Medicare Part
Page 207 and 208:
Refer any questions to your team at
Page 209 and 210:
Chapter 12: CONTRACTING Introductio
Page 211 and 212:
Orange Guide - Chapter 12: Contract
Page 213 and 214:
Orange Guide - Chapter 12: Contract
Page 215 and 216:
Key Points to Ensure Compliance Ora
Page 217 and 218:
Chapter 13: HEALTH SCREENINGS Intro
Page 219 and 220:
Orange Guide - Chapter 13: Health S
Page 221 and 222:
If organized by Pfizer: Orange Guid
Page 223 and 224:
Orange Guide - Chapter 13: Health S
Page 225 and 226:
Orange Guide - Chapter 14: CGC Tool
Page 227 and 228:
Orange Guide - Chapter 14: CGC Tool
Page 229 and 230:
Discussing Pfizer Products While Me
Page 231 and 232:
Orange Guide - Chapter 15: Non-Reba
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Orange Guide - Chapter 16: Consumer
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Providing Food to Consumers at a Di
Page 245 and 246:
Page 247 and 248:
Content of Consumer Slide Decks Att
Page 249 and 250:
Adverse Events Orange Guide - Chapt
Page 251 and 252:
Orange Guide - Chapter 17: State La
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
California Orange Guide - Chapter 1
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Educational Items Orange Guide - Ch
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Orange Guide - Chapter 18: Meals, E
Page 291 and 292:
Page 293 and 294:
Meals to HCPs Orange Guide - Chapte
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Orange Guide - Chapter 19: Sales Ac
Page 313 and 314:
Pricing Considerations Orange Guide
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321:
show all

White Guide and Orange Guide Formatting Project - Pfizer

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?